Screener/Healthcare/Biotechnology

ARWR

Arrowhead Pharmaceuticals, Inc.NASDAQ
$56.19-0.56 (-0.99%)
Mid CapHealthcareFastest GrowingHigh ROE
$9.57
$76.76
$55.01
$56.88
EPS (TTM)$1.53
P/E Ratio36.72
Dividend Yield—
Market Cap$7.98B
Volume1.12M
Prev Close$56.67
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$264.0M$28.2M$0.22100.0%10.7%
Q4 '25$256.5M$16.1M$-0.18100.0%6.3%
Q3 '25$27.8M-$178.7M$-1.2677.6%-643.4%
Q2 '25$542.7M$367.9M$2.75100.0%67.8%
Q1 '25$2.5M-$175.2M$-1.23100.0%-7008.7%
Q4 '24$0-$173.3M$-1.37——
Q3 '24$0-$174.0M$-1.38——
Q2 '24$0-$127.0M$-1.02——
Get Your Daily Market Recap